Nomograms for overall survival (OS) and progression-free survival (PFS) in metastatic colorectal cancer (mCRC): Construction from 19,678 ARCAD patients.

Authors

Katrin Sjoquist

Katrin Marie Sjoquist

NHMRC Clinical Trials Centre, University of Sydney and Cancer Care Centre, St. George Hospital, Sydney, Australia

Katrin Marie Sjoquist , Lindsay A. Renfro , John Simes , Niall C. Tebbutt , Stephen John Clarke , Jeffrey P. Meyers , Wilson I. Gonsalves , Richard Adams , Matthew T. Seymour , Leonard Saltz , Hans Schmoll , Daniel J. Sargent , Aimery De Gramont , John Raymond Zalcberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 659)

DOI

10.1200/jco.2015.33.3_suppl.659

Abstract #

659

Poster Bd #

D1

Abstract Disclosures

Similar Posters

Poster

2012 Gastrointestinal Cancers Symposium

CD133 status influences in prognosis of patients with metastatic colorectal cancer receiving cetuximab.

CD133 status influences in prognosis of patients with metastatic colorectal cancer receiving cetuximab.

First Author: Dai Inoue

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.

Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.

First Author: Sandra Algaze

First Author: Sang Hoon Chun